Aims To describe trends in risk factor control and serious hypoglycaemia in people with type
1 diabetes and to assess the effect of starting continuous glucose monitoring (CGM) in the …

Aims To use data from the Norwegian Diabetes Registry for Adults and Statistics Norway to
assess factors associated with glycaemic control in type 1 diabetes. Methods The analyses …

Aims/hypothesis The aim of this work was to examine whether glycaemic control has
improved in those with type 1 diabetes in Scotland between 2004 and 2016, and whether …

Aims Hypoglycemia remains a barrier in maintaining good glycemic control. Several
technologies using continuous glucose monitoring have demonstrated improved glycemic …

Background As previous clinical trials have demonstrated the improvements of glycated A1c
(HbA1c) and time in range with continuous glucose monitoring (CGM) use, CGM is …

Purpose Improving glycaemic control in type 2 diabetes (T2D) is essential to reducing social
and health-economic burden of diabetes-related complications. Continuous glucose …

Aims/hypothesis The aim of this work was to assess the effectiveness of continuous glucose
monitoring (CGM) vs self-monitoring of blood glucose (SMBG) in maintaining glycaemic …

Background The effect of continuous glucose monitoring on the risk of severe
hypoglycaemia and ketoacidosis in patients with diabetes is unclear. We investigated …

Background Patients with type 1 diabetes mellitus (T1DM) and poor glycaemic control are at
high risk of developing microvascular and macrovascular complications. The aim of this …

Background Severe hypoglycaemia carries a significant risk of morbidity and mortality for
people with type 1 diabetes. Economic costs are also high, estimated at approximately£ 13 …